Unicycive Therapeutics (UNCY) Non-cash Items (2020 - 2026)

Unicycive Therapeutics (UNCY) has 7 years of Non-cash Items data on file, last reported at $11.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 6176.19% year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.9 million (up 6176.19% YoY), and the FY2025 full-year result was $10.3 million, up 1367.66% from the prior year.
• Non-cash Items for Q1 2026 stood at $11.9 million, up from $10.3 million in the prior quarter.
• Across five years, Non-cash Items topped out at $35.3 million in Q3 2023 and bottomed at $48000.0 in Q2 2024.
• The 5-year median for Non-cash Items is $4.7 million (2024), against an average of $6.6 million.
• The widest annual swing landed in 2024, when Non-cash Items tumbled 98.4%; it then surged 11170.83% in 2025.
• A 5-year view of Non-cash Items shows it stood at $52000.0 in 2022, then surged by 2200.0% to $1.2 million in 2023, then plunged by 41.05% to $705000.0 in 2024, then soared by 1367.66% to $10.3 million in 2025, then increased by 14.64% to $11.9 million in 2026.
• The last three Non-cash Items figures came in at $11.9 million (Q1 2026), $10.3 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.

Peer Comparison